Main Article Content

Abstract

An expeditious synthesis of series of novel 1,3,5-thiadiazine (5a-f) and (6a-f) derivatives have been described. These compounds were synthesized by reaction of 1-(N-((6-methyl-2-(p-tolyloxy)quinoline-3-yl)methylene)carbamimidoyl)-3-arylthiourea (3a-b) derivatives with N-aryl isocyanodichloride (4a-c) in chloroform followed by basification with dilute NH4OH to give the target compounds 5a-f; which were acetylated further to afford six novel 1,3,5-thiadiazin-3-(6H)-yl)ethanone (6a-f) derivatives. Synthesis of intermediate compounds 3a-b was obtained by reacting 6-methyl-2-(p-tolyloxy)quinoline-3-carbaldehyde (2a) and 1-carbamimidoyl-3-aryllthiourea (1a-b) in chloroform. Structures of compounds 5a-f and 6a-f were established by FTIR, 1H & 13C NMR, mass spectra and further supported by elemental analysis. All synthesized compounds were investigated for their in vitro antimicrobial screening against a panel of pathogenic microorganism comprising S. aureus as Gram positive while E. coli, P. vulgaris, S. typhi as Gram-negative bacterial strains.

Keywords

p-Tolyloxy quinoline-3-carbaldehyde Aryl imino 1,3,5-Thiadiazines Antimicrobial activity

Article Details

How to Cite
Idrees, M., J. Siddiqui, N., G. Bodkhe, Y., & Kola, S. (2020). Synthesis and Characterization of Novel 1,3,5-Thiadiazine Derivatives Integrated with Quinoline Moiety as Potent Antimicrobial Agents. Asian Journal of Organic & Medicinal Chemistry, 5(2), 149–155. https://doi.org/10.14233/ajomc.2020.AJOMC-P262

References

  1. Z.A. Kaplancikli, G. Turan-Zitouni, A. Özdemir and G. Revial, New Triazole and Triazolothiadiazine Derivatives as Possible Antimicrobial Agents, Eur. J. Med. Chem., 43, 155 (2008); https://doi.org/10.1016/j.ejmech.2007.03.019
  2. R.S. Joshi, P.G. Mandhane, A.V. Chate and C.H. Gill, Synthesis of Novel Series of Various Substituted 1-(5-(2-p-tolyloxyquinolin-3-yl)-2-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-yl)ethanone and its Antibacterial Activity, J. Korean Chem. Soc., 55, 760 (2011); https://doi.org/10.5012/jkcs.2011.55.5.760
  3. E. Saglam, S. Sarac, E. Kilic, M. Ozalp and M. Ertan, Synthesis and Antimicrobial Activity of Some 3,5-Disubstituted-tetrahydro-2H-1,3,5-thiadiazine2-thione Derivatives, Turk. J. Pharm. Sci., 8, 159 (2011).
  4. O.O. Ajani, O.B. Familoni, F. Wu, J.O. Echeme and Z. Sujiang, Room Temperature Synthesis and Antibacterial Activity of New Sulfonamides Containing N,N-Diethyl Substituted Amido Moieties, Int. J. Med. Chem., 2012, 367815 (2012); https://doi.org/10.1155/2012/367815
  5. S.F. Vanparia, T.S. Patel, R.B. Dixit and B.C. Dixit, Synthesis and in vitro Antimicrobial Activity of Some Newer Quinazolinone-Sulfon-amide Linked Hybrid Heterocyclic Entities Derived from Glycine, Med. Chem. Res., 22, 5184 (2013); https://doi.org/10.1007/s00044-012-0320-7
  6. N. Polkam, P. Rayam, J.S. Anireddy, S. Yennam, H.S. Anantaraju, S. Dharmarajan, Y. Perumal, S.S. Kotapalli, R. Ummanni and S. Balasubramanian, Synthesis, in vitro Anticancer and Antimycobacterial Evaluation of New 5-(2,5-Dimethoxyphenyl)-1,3,4-thiadiazole-2-amino Derivatives, Bioorg. Med. Chem. Lett., 25, 1398 (2015); https://doi.org/10.1016/j.bmcl.2015.02.052
  7. N. Arshad, J. Hashim, Irfanullah, M.A. Minhas, J. Aslam, T. Ashraf, S.Z. Hamid, T. Iqbal and S. Javed, New Series of 3,5-Disubstituted Tetrahydro-2H-1,3,5-thiadiazine thione (THTT) Derivatives: Synthesis and Potent Antileishmanial Activity, Bioorg. Med. Chem. Lett., 28, 3251 (2018); https://doi.org/10.1016/j.bmcl.2018.07.045
  8. X. Ji, Z. Zhong, X. Chen, R. Xing, S. Liu, L. Wang and P. Li, Preparation of 1,3,5-Thiadiazine-2-thione Derivatives of Chitosan and their Potential Antioxidant Activity in vitro, Bioorg. Med. Chem. Lett., 17, 4275 (2007); https://doi.org/10.1016/j.bmcl.2007.05.020
  9. J. Coro, R. Perez, H. Rodriguez, M. Suarez, C. Vega, M. Rolon, D. Montero, J. Nogal and A. Gomez-Barrio, Synthesis and Antiprotozoan Evaluation of New Alkyl-Linked bis(2-Thioxo-[1,3,5]thiadiazinan-3-yl)carboxylic Acids, Bioorg. Med. Chem., 13, 3413 (2005); https://doi.org/10.1016/j.bmc.2005.03.009
  10. J.C. Bermello, R.P. Piñeiro, L.M. Fidalgo, H.R. Cabrera and M.S. Navarro, Thiadiazine Derivatives as Antiprotozoal New Drugs, Open Med. Chem. J., 5, 51 (2011); https://doi.org/10.2174/1874104501105010051
  11. J. Coro, S. Little, V. Yardley, M. Suarez, H. Rodríguez, N. Martin and R. Perez-Pineiro, Synthesis and Antiprotozoal Evaluation of New N4-(Benzyl)spermidyl-Linked bis(1,3,5-thiadiazinane-2-thiones), Arch. Pharm., 341, 708 (2008); https://doi.org/10.1002/ardp.200800011
  12. J. Coro, R. Pérez, H. Rodríguez, M. Suárez, C. Vega, M. Rolón, D. Montero, J.J. Nogal and A. Gómez-Barrio, Synthesis and Antiprotozoan Evaluation of New Alkyl-Linked bis(2-Thioxo-[1,3,5]thiadiazinan-3-yl)carboxylic acids, Bioorg. Med. Chem., 13, 3413 (2005); https://doi.org/10.1016/j.bmc.2005.03.009
  13. T. Aboul-Fadl and K. Hassanin, Tetrahydro-2H-1,3,5-thiadiazin-5-(4-pyridylcarboxamide)-2-thione Derivatives as Prodrugs for Isoniazid, Synthesis, Investigations and in vitro Antituberculous Activity, Pharmazie, 54, 244 (1999).
  14. R. Pérez, H. Rodríguez, E. Pérez, M. Suárez, O. Reyes, L.J. González, A.L. de Cerain, O. Ezpelata, C. Pérez and C. Ochoa, Study on the Decomposition Products of Thiadiazinthione and their Anticancer Properties, Arzneimittelforschung, 50, 854 (2000); https://doi.org/10.1055/s-0031-1300301
  15. M.H. Semreen, A.N. El-Shorbagi, T.H. Al-Tel and I.M. Alsalahat, Targeting g-Aminobutyric Acid (GABA) Carriers to the Brain: Potential Relevance as Antiepileptic Pro-Drugs, Med. Chem., 6, 144 (2010); https://doi.org/10.2174/1573406411006030144
  16. A.N. El-Shorbagi, Disubstituted Tetrahydro-2H-1,3,5-thiadiazine-2-thiones as Lipophilic Carriers for Glutamine and Glutamic Acid, Bull. Pharm. Sci. (Assiut), 23, 31 (2000); https://doi.org/10.21608/bfsa.2000.66128
  17. G. Chen, J. He, F. Zhang and Y. Li, Synthesis and Atructure-Activity Relationship of New Kind Inhibitor of Mercapto-proteinases, Shoudu Yike Daxue Xuebao, 23, 107 (2002).
  18. M.A. Hussein, A.N. El-Shorbagi and A.R. Khallil, Synthesis and Anti-fungal Activity of 3,3¢-Ethylenebis(5-alkyl-1,3,5-thiadiazine-2-thiones), Arch. Pharm. Pharm. Med. Chem., 334, 305 (2001); https://doi.org/10.1002/1521-4184(200110)334:10<305::AID-ARDP305>3.0.CO;2-O
  19. C. Camoutsis, A. Geronikaki, A. Ciric, M. Sokoviæ, P. Zoumpoulakis and M. Zervou, Sulfonamide-1,2,4-thiadiazole Derivatives as Antifungal and Antibacterial Agents: Synthesis, Biological Evaluation, Lipophilicity and Conformational Studies, Chem. Pharm. Bull. (Tokyo), 58, 160 (2010); https://doi.org/10.1248/cpb.58.160
  20. S. Chandra, S. Gautam, A. Kumar and M. Madan, Coordination mode of Pentadentate Ligand Derivative of 5-amino-1,3,4-thiadiazole-2-thiol with Nickel(II) and Copper(II) Metal Ions: Synthesis, Spectroscopic Characterization, Molecular Modeling and Fungicidal Study, Spectrochim. Acta A Mol. Biomol. Spectrosc., 136, 672 (2015); https://doi.org/10.1016/j.saa.2014.09.081
  21. A. Rieche, G. Hilgetag, A. Martini, O. Nejedly and J. Schlegel, New Compounds with Bactericidal, Fungicidal and Virus Growth-Inhibiting Effects I. 2-Thiotetrahydro1,3,5-thiadiazine (Carbothialdine) and Dithiocarbamic Acid Salts, Arch. Pharm., 293, 957 (1960); https://doi.org/10.1002/ardp.19602931102
  22. T. Aboul-Fadl, M.A. Hussein, A.N. El-Shorbagi and A.R. Khallil, New 2H-Tetrahydro-1,3,5-thiadiazine-2-thiones Incorporating Glycine and Glycinamide as Potential Antifungal Agents, Arch. Pharm., 335, 438 (2002); https://doi.org/10.1002/1521-4184(200212)335:9<438::AID-ARDP438>3.0.CO;2-E
  23. R. Carrasco, J.A. Padron, R. Pérez, H. Rodriguez, M. Suarez and C. Ochoa,, Quantitative Structure Antitumoral-Activity Relationships of Thiadiazinthione Derivatives using the Novel Hybrid Molecular Index pMRchi, J. Pharm. Pharm. Sci., 8, 586 (2005).
  24. A.A. Radwan, A. Al-Dhfyan, M.K. Abdel-Hamid, A.A. Al-Badr and T. Aboul-Fadl, 3,5-Disubstituted Thiadiazine-2-thiones: New Cell-Cycle Inhibitors, Arch. Pharm. Res., 35, 35 (2012); https://doi.org/10.1007/s12272-012-0104-0
  25. A.-N. El-Shorbagi, M. El-Naggar, H. Tarazi, S. Chaudhary, H. Abdu-Allah, F. Hersi and H. Omar, Bis-(5-Substituted-2-thiono-1,3,5-thiadiazinan-3-yl)butane as a Scaffold of Anti-Proliferative Activity, Blended by a Multicomponent Process, Med. Chem. Res., 27, 1103 (2018); https://doi.org/10.1007/s00044-018-2133-9
  26. R.R. Soares, J.M.F. da Silva, B.C. Carlos, C.C. da Fonseca, L.S.A. de Souza, F.V. Lopes, R.M. de Paula Dias, P.O.L. Moreira, C. Abramo, G.H.R. Viana, F. de Pila Varotti, A.D. da Silva and K.K.G. Scopel, New Quinoline Derivatives Demonstrate a Promising Antimalarial Activity Against Plasmodium falciparum in vitro and Plasmodium berghei in vivo, Bioorg. Med. Chem. Lett., 25, 2308 (2015); https://doi.org/10.1016/j.bmcl.2015.04.014
  27. E.Y. Bibik, O.G. Yaroshevskaya, A.V. Devdera, A.V. Demenko, V.V. Zakharov, K.A. Frolov, V.V. Dotsenko and S.G. Krivokolysko, Search for Anti-Inflammatory Agents in the Tetrahydropyrido[2,1-b][1,3,5]-Thiadiazine Series, Pharm. Chem. J., 51, 648 (2017); https://doi.org/10.1007/s11094-017-1669-1
  28. S. Vega and M.E. Arranz, 4H-thieno[3,4-e ]- and 4H-pyrazolo[4,3-e]-1,2,4-thiadiazine 1,1-dioxides Synthesis, Chemical Properties and Evaluation of their Potential Cardiovascular Activity, J. Heterocycl. Chem., 41, 45 (2004); https://doi.org/10.1002/jhet.5570410107
  29. I. Khan, S. Zaib, A. Ibrar, N.H. Rama, J. Simpson and J. Iqbal, Synthesis, Crystal Structure and Biological Evaluation of Some Novel 1,2,4-Triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines, Eur. J. Med. Chem., 78, 167 (2014); https://doi.org/10.1016/j.ejmech.2014.03.046
  30. J.J. Luszczki, M. Karpiñska, J. Matysiak and A. Niewiadomy, Characterization and Preliminary Anticonvulsant Assessment of Some 1,3,4-Thiadiazole Derivatives, Pharmacol. Rep., 67, 588 (2015); https://doi.org/10.1016/j.pharep.2014.12.008
  31. Y. Hu, C.Y. Li, X.-M. Wang, Y.-H. Yang and H.-L. Zhu, 1,3,4-Thiadia-zole: Synthesis, Reactions and Applications in Medicinal, Agricultural and Materials Chemistry, Chem. Rev., 114, 5572 (2014); https://doi.org/10.1021/cr400131u